New Arrivals
| Chemical Structure | Cat. No. | Product Name | CAS No. |
|---|
![Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate Chemical Structure](https://img.biochemsafebuy.com/uploads/company8/20241104/1730691612_hxxyt.gif "Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate Chemical Structure") |
BCP49692 | Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate New | 2641824-60-2 |
 |
BCP49691 | 5-Bromo-3-(3-((tert-butyldiphenylsilyl)oxy)-2,2-dimethylpropyl)-2-iodo-1H-indole New | 2641451-43-4 |
 |
BCP49689 | KRAS G12D inhibitor 18 New | 2922732-54-3 |
KRAS G12D inhibitor 18 is a potent KRAS G12D inhibitor.
|
|||
 |
BCP49690 | Tromethamine hydrochloride New | 1185-53-1 |
Trometamol hydrochloride is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo. Trometamol hydrochloride is an effective amine compound for pH control in the physiological range.
|
|||
 |
BCP21987 | 3-Aminobenzaldehyde New | 1709-44-0 |
 |
BCP21111 | Pretomanid New | 187235-37-6 |
PA-824 is an experimental anti-tuberculosis drug and one of two nitroimidazoles in phase II clinical trials to treat tuberculosis.
|
|||
 |
BCP43839 | Tafluprost Impurity 21 New | 1563176-58-8 |
 |
BCP09072 | Lificiguat New | 170632-47-0 |
YC-1(Lificiguat) is a soluble guanylyl cyclase(sGC) activator; binds to the heme-containing domain of the β subunit with Kd value of 0.6-1.1 μM in the presence of CO.
|
|||
 |
BCP28865 | CD1530 New | 107430-66-0 |
CD-1530 is a retinoic acid receptor γ selective agonist.
|
|||
 |
BCP44295 | Exatecan Intermediate 6 New | 143655-58-7 |
Exatecan Intermediate 6 is the intermediate of Exatecan(DX-8951) which is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research.
|
|||
 |
BCP00675 | SB202190 New | 152121-30-7 |
SB 202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinase. SB202190 binds within the ATP pocket of the active kinase (Kd = 38 nM, as measured in recombinant human p38), and selectively inhibits the p38α and β isoforms (IC50 = 50 and 100 nM at SAPK2a/p38 and SAPK2b/p38β2 respectively).
|
|||
 |
BCP49688 | GOAT-IN-1 New | 1452473-54-9 |
GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT) that may be useful for the prophylaxis or treatment of diabetes, hyperlipidemia, non-alcoholic fatty liver, Alzheimer's disease, Parkinson's disease, cerebrovascular dementia, and cerebral infarction.
|
|||
 |
BCP02612 | Torin 2 New | 1223001-51-1 |
Torin 2 is potent and selective mTOR inhibitor (IC50 = 2.1 nM).
|
|||
 |
BCP49687 | Ciwujianoside C3 New | 114906-74-0 |
Ciwujianoside C3 comes from Acanthopanax senticosus.
|
|||
 |
BCP41819 | (R)-Camptothecin New | 110351-92-3 |
(R)-(-)-Camptothecin is an alkaloid that has been used for the treatment of cancer.
|
|||
 |
BCP29935 | Trisodium UDP glucuronic acid New | 63700-19-6 |
UDP-D-glucuronide trisodium salt is a crucial compound used for drug metabolism studies.
|
|||
 |
BCP43824 | Bis(1,5-cyclooctadiene)dimethoxydiiridium New | 12148-71-9 |
 |
BCP41126 | SN-001 New | 727699-84-5 |
SN-001 is a STING inhibitor with an IC50 of 3.82 μM.
|
|||
 |
BCP49686 | Glycochenodeoxycholic acid New | 640-79-9 |
Glycochenodeoxycholic acid is a bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component. It has a role as a human metabolite. It is functionally related to a chenodeoxycholic acid. It is a conjugate acid of a glycochenodeoxycholate.
|
|||
 |
BCP10027 | UDCS New | 128-13-2 |
Ursodiol reduces cholesterol absorption and is used to dissolve gallstones.
|
|||
